Herold Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Herold Advisors's LLY Position: Q3 2026 in Review
Herold Advisors reduced its Eli Lilly (LLY) stake by 3.5% in Q3 2026, selling an estimated $440K and leaving 10,177 shares worth $11.8M. The position accounts for 2.3% of the portfolio, ranked #5.
Herold Advisors first reported a position in LLY in Q3 2021 and has held it in 21 quarters since. The position peaked at $12.7M in Q2 2026. 900 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Herold Advisors held 10,177 shares of Eli Lilly worth $11.8M as of Q3 2026.
- Herold Advisors sold 373 Eli Lilly shares in Q3 2026, an estimated $440K.
- Eli Lilly made up 2.3% of Herold Advisors's portfolio in Q3 2026, its #5 holding.
- Herold Advisors first reported a position in Eli Lilly in Q3 2021 and has held it in 21 quarters since.
- Herold Advisors's Eli Lilly position peaked at $12.7M in Q2 2026.
- 900 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Herold Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.